The incoming employees at the biopharmaceutical giant will zero in on mRNA, structural biology, and viral vaccine research ...
GSK is moving out of its 635K SF footprint at 14200 Shady Grove Road, where it is the sole tenant, just before its lease ...
European and US real estate asset manager and investor, Global Mutual, is delighted to announce that phase 1 of the retrofit ...
Sustainability and joint working But Belson notes that building trust must go beyond internal projects and involve external efforts as well. He highlights GSK’s recently announced sustainability ...
He was surprised to discover, for example, that a photo of the GSK headquarters building attracted more positive comments than a story about a community partnership. A recent example of content ...
Agencies have always strived to build trust with their pharma clients, but that task is becoming more arduous as AI takes center stage.
With Chinese firms becoming major players in drug development, the traditional balance of power in global pharmaceuticals is ...
Navigator Medicines, Inc., a clinical-stage biotech company leading the advancement of biologics for targeted immune ...
Orchard Therapeutics has tasked Robin Kenselaar with accelerating growth of Lenmeldy, the world’s most expensive drug, ...
Q4 2024 Earnings Call Transcript February 13, 2025 Blueprint Medicines Corporation misses on earnings expectations. Reported ...
Beleaguered shareholders of BP Plc who’ve watched their investment lag over the past few years are banking on activist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results